Search Results

Site Search

CPT Codes and LOINC Update: March 2019 - Insights

View a full list of new CPT codes, Test Classification Updates, LOINC Codes, and Z-Codes posted to mayocliniclabs.com during the month of March 2019.

Mayo Clinic Researchers Develop Prediction Tool for Kidney Stones - Insights

Mayo Clinic researchers are tracking the familiar characteristics of kidney stone formers in an online prediction tool that could help sufferers anticipate if they'll experience future episodes.

Mayo Clinic Laboratory and Pathology Research Roundup: May 28 - Insights

This week’s Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.

Mayo Clinic Laboratory and Pathology Research Roundup: June 12 - Insights

This week’s Research Roundup highlights noninvasive assessment of renal fibrosis with magnetization transfer MR imaging.

CPT codes and LOINC update: August 2023 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of August.

CPT codes and LOINC update: December 2023 - Insights

This page includes updates posted to Mayo Clinic Labs during the month of December.

Mayo Clinic Laboratory and pathology research roundup: October 4 - Insights

This week's research roundup features: Tumor microenvironment CD14+ cells correlate with poor overall survival in patients with early-stage lung adenocarcinoma

Mayo Clinic Laboratory and pathology research roundup: September 13 - Insights

This week's research roundup features: A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction

Mayo Clinic Laboratory and pathology research roundup: November 8 - Insights

This week's research roundup features: Evaluating the significance of pancreatobiliary fluorescence in situ hybridization polysomy on prognosis in de novo cholangiocarcinoma

Mayo Clinic Laboratory and pathology research roundup: October 18 - Insights

This week's research roundup features: How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?